New England Biolabs® launches NEBNext Direct® Genotyping Solution for cost-effective, sequence-based genotyping in AgBio applications

New kit offers plant breeders a more targeted high-throughput solution using novel target enrichment technology.

Written byNew England BioLabs
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

New England Biolabs (NEB®) announced the launch of the NEBNext Direct Genotyping Solution, representing the first capture-based approach for high-throughput genotyping for a wide variety of applications in Agricultural Biotechnology (AgBio).

"We are excited to introduce the NEBNext Direct Genotyping Solution, which was initially developed to address the demands of marker-assisted plant breeders for a cost-effective, high-throughput genotyping method," said Andrew Barry, Sr. Manager of Global Business Development at NEB. "The stringent requirements of plant breeding forced us to push the limits on reducing the cost per assay, while maintaining high-specificity for the target markers, resulting in a product with a wide range of utility"

The NEBNext Direct Genotyping Solution combines highly multiplexed, capture-based enrichment with maximum efficiency and next generation sequencing (NGS) to deliver a one day, automatable genotyping workflow. Applicable for marker ranges spanning 100 to 5,000 markers, pre-capture multiplexing of up to 96 samples, in addition to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Graphic of amino acid chains folded into proteins

Expi293™ PRO Expression System: Higher Yields Across a Wider Variety of Proteins

Thermo Fisher Logo